Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Environ Toxicol ; 35(5): 543-552, 2020 May.
Artigo em Inglês | MEDLINE | ID: mdl-31820560

RESUMO

Bisphenol A (BPA) has been widely reported to exert endocrine disrupting effects, including the induction of adipogenesis in cultured preadipocytes and intact animals. Because of the potential harm to human health, BPA is being substituted by structurally related bisphenols. Whether or not such BPA analogues are safe substitutes, however, remains largely unknown. Here, we investigated the potential of bisphenol B (BPB), bisphenol E (BPE), bisphenol F (BPF), bisphenol S (BPS), and 4-cumylphenol (4-CP) to affect lipid and hormone levels in 3 T3-L1 cells. We found that BPB, BPE, BPF, BPS, and 4-CP all affected lipid accumulation and leptin levels to the same extent and potencies as BPA. Based on these and other results, we conclude that these BPA analogues and 4-CP most likely will elicit similar effects on adipocytes as BPA. Using them to substitute BPA in products should be done with caution.


Assuntos
Adipócitos/efeitos dos fármacos , Compostos Benzidrílicos/toxicidade , Disruptores Endócrinos/toxicidade , Metabolismo dos Lipídeos/efeitos dos fármacos , Fenóis/toxicidade , Sulfonas/toxicidade , Células 3T3-L1 , Adipócitos/metabolismo , Animais , Biomarcadores/metabolismo , Sobrevivência Celular/efeitos dos fármacos , Humanos , Leptina/metabolismo , Metabolismo dos Lipídeos/genética , Camundongos , Transcriptoma/efeitos dos fármacos
2.
Environ Res ; 142: 407-13, 2015 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-26232659

RESUMO

BACKGROUND: Several persistent organochlorine pollutants (POPs) possess endocrine disrupting abilities, thereby potentially leading to an increased risk of obesity and metabolic diseases, especially if the exposure occurs during prenatal life. We have previously found associations between prenatal POP exposures and increased BMI, waist circumference and change in BMI from 5 to 7 years of age, though only among girls with overweight mothers. OBJECTIVES: In the same birth cohort, we investigated whether prenatal POP exposure was associated with serum concentrations of insulin and leptin among 5-year-old children, thus possibly mediating the association with overweight and obesity at 7 years of age. METHODS: The analyses were based on a prospective Faroese Birth Cohort (n=656), recruited between 1997 and 2000. Major POPs, polychlorinated biphenyls (PCBs), p,p'-dichlorodiphenyldichloroethylene (DDE) and hexachlorobenzene (HCB), were measured in maternal pregnancy serum and breast milk. Children were followed-up at the age of 5 years where a non-fasting blood sample was drawn; 520 children (273 boys and 247 girls) had adequate serum amounts available for biomarker analyses by Luminex® technology. Insulin and leptin concentrations were transformed from continuous to binary variables, using the 75th percentile as a cut-off point. Multiple logistic regression was used to investigate associations between prenatal POP exposures and non-fasting serum concentrations of insulin and leptin at age 5 while taking into account confounders. RESULTS: Girls with highest prenatal POP exposure were more likely to have high non-fasting insulin levels (PCBs 4th quartile: OR=3.71; 95% CI: 1.36, 10.01. DDE 4th quartile: OR=2.75; 95% CI: 1.09, 6.90. HCB 4th quartile: OR=1.98; 95% CI: 1.06, 3.69) compared to girls in the lowest quartile. No significant associations were observed with leptin, or among boys. A mediating effect of insulin or leptin on later obesity was not observed. CONCLUSION: These findings suggest, that for girls, prenatal exposure to POPs may play a role for later development of metabolic diseases by affecting the level of insulin.


Assuntos
Disruptores Endócrinos/análise , Exposição Ambiental/análise , Hidrocarbonetos Clorados/análise , Insulina/sangue , Efeitos Tardios da Exposição Pré-Natal/sangue , Criança , Pré-Escolar , Estudos de Coortes , Disruptores Endócrinos/efeitos adversos , Exposição Ambiental/efeitos adversos , Feminino , Humanos , Hidrocarbonetos Clorados/efeitos adversos , Leptina/sangue , Modelos Logísticos , Masculino , Obesidade/sangue , Obesidade/etiologia , Gravidez , Efeitos Tardios da Exposição Pré-Natal/induzido quimicamente , Estudos Prospectivos , Fatores Sexuais
3.
Food Chem Toxicol ; 41(10): 1315-23, 2003 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-12909264

RESUMO

The potential beneficial or adverse affect of prolonged dietary administration of moderate to high doses (1-100 mg/kg diet) of the antioxidants, lycopene, quercetin and resveratrol or a mixture of lycopene and quercetin was investigated in male F344 rats. Selected markers for toxicity and defense mechanisms were assayed in blood, liver and colon and the impact of the antioxidant administrations on putative preneoplastic changes in liver and colon was assessed. The dietary carcinogen, 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) (200 mg/kg diet) served as a pro-oxidant, genotoxicity and general toxicity control. IQ increased the levels of protein and DNA oxidation products in plasma, the area of glutathione S-transferase-placental form positive (GST-P) foci in the liver as well as the number of colonic aberrant crypt foci (ACF). All antioxidants and the antioxidant combination significantly increased the level of lymphocytic DNA damage, to an extent comparable with the effect induced by IQ. In contrast to the control group where no GST-P foci were detected, GST-P foci were detected in animals exposed to quercetin, lycopene and the combination of the two. However, the increase in the volume of GST-P foci did not reach statistical significance. The present results indicate that moderate to high doses of common dietary antioxidants can damage lymphocyte DNA and induce low levels of preneoplastic liver lesions in experimental animals. Long-term exposure to moderate to high doses of antioxidants may thus via pro-oxidative mechanisms and non-oxidative mechanisms modulate carcinogenesis.


Assuntos
Antioxidantes/farmacologia , Hormônios/sangue , Estresse Oxidativo/efeitos dos fármacos , Lesões Pré-Cancerosas/tratamento farmacológico , Quinolinas/farmacologia , Animais , Biomarcadores , Carotenoides/farmacologia , Colo/patologia , Ensaio Cometa , Dieta , Glutationa Transferase/metabolismo , Imuno-Histoquímica , Fígado/efeitos dos fármacos , Fígado/enzimologia , Licopeno , Masculino , Oxirredução , Placenta/efeitos dos fármacos , Placenta/enzimologia , Quercetina/farmacologia , Ratos , Ratos Endogâmicos F344 , Resveratrol , Estilbenos/farmacologia
4.
Toxicol Sci ; 106(2): 376-83, 2008 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-18713765

RESUMO

Parabens are a group of antimicrobial preservatives widely used in cosmetics, pharmaceuticals, and in foods. Previous in vitro and in vivo studies have shown weak estrogenic effects of some parabens. Thus, especially, exposure of fetus and infants via the mother is a matter of concern. In order to obtain more knowledge about the distribution of ethyl paraben and butyl paraben in pregnant rats and pups after perinatal exposure, the presented study was designed. The data show response and distribution of ethyl paraben and butyl paraben in maternal rat plasma, pools of amniotic fluids, placenta, whole-body fetuses, and in fetal liver after dosing of dams with 100, 200, and 400 mg/kg body weight (bw)/day from gestational day 7 to 21. After cesarean section of dams, the fluids and tissues were collected, deconjugated, and purified by solid-phase extraction, and ethyl paraben and butyl paraben were analyzed by liquid chromatography-tandem mass spectrometry. Markedly higher levels of ethyl paraben compared to butyl paraben were found in all fluids and tissues. Both ethyl paraben and butyl paraben in maternal plasma, livers, and whole-body tissues from fetus seemed to be saturated after dosing with >or= 100 mg/kg bw/day, while both compounds were excreted into amniotic fluid in a dose-dependent manner. Significant difference was found between the level of ethyl paraben in maternal plasma and amniotic fluid after dosing with 200 mg/kg bw/day as well as between the levels of butyl paraben in maternal plasma and amniotic fluid after dosing with 100, 200, and 400 mg/kg bw/day.


Assuntos
Líquido Amniótico/metabolismo , Parabenos/metabolismo , Animais , Cromatografia Líquida de Alta Pressão , Cromatografia Líquida , Feminino , Injeções Subcutâneas , Masculino , Parabenos/administração & dosagem , Parabenos/farmacocinética , Placenta/metabolismo , Gravidez , Ratos , Ratos Wistar , Padrões de Referência , Sensibilidade e Especificidade , Espectrometria de Massas em Tandem , Distribuição Tecidual
5.
Nutr Cancer ; 46(1): 73-81, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-12925307

RESUMO

The aim of the present study was to investigate the effect of in utero administration of coumestrol, equol, and selenium-enriched yeast on selected hepatic phase 2 enzymes, plasma hormone levels, and markers for redox status in plasma and red blood cells (RBCs). The test compounds were administered via the diet to pregnant Sprague-Dawley rats throughout gestation. Within 24 h following delivery dams and offspring were sacrificed, and blood, liver, and reproductive organs were sampled. Coumestrol, equol, and selenium-enriched yeast did not significantly affect hepatic glutathione S-transferase (GST), quinone reductase (QR), or RBC glutathione peroxidase (GPx) in the offspring, whereas significant increases in GST, QR, and GPx activities in dams were observed following administration of selenium-enriched yeast. The level of 17beta-estradiol in offspring from coumestrol-exposed dams was significantly increased compared with the control. The present results indicate that selenium-enriched yeast, coumestrol, and equol affect selected hepatic phase 2 enzymes and GPx in RBC in dams, whereas the offspring in general were refractive to the employed treatments. Further studies are warranted to investigate whether the observed in utero effects imposed by the selected plant compounds confer permanent alterations on the health status of the animal resulting in an altered resistance to cancer.


Assuntos
Cumestrol/farmacologia , Enzimas/efeitos dos fármacos , Isoflavonas/farmacologia , Troca Materno-Fetal/fisiologia , Oxirredutases/efeitos dos fármacos , Selênio/farmacologia , Análise de Variância , Animais , Antioxidantes/administração & dosagem , Antioxidantes/metabolismo , Antioxidantes/farmacologia , Biomarcadores/análise , Cumestrol/administração & dosagem , Cumestrol/metabolismo , Equol , Estradiol/sangue , Feminino , Hormônios/sangue , Isoflavonas/administração & dosagem , Isoflavonas/metabolismo , Lipídeos/sangue , Fígado/efeitos dos fármacos , Fígado/enzimologia , Masculino , Malondialdeído/sangue , Tamanho do Órgão/efeitos dos fármacos , Oxirredução/efeitos dos fármacos , Gravidez , Ratos , Ratos Sprague-Dawley , Selênio/administração & dosagem , Selênio/sangue , Útero/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA